Penn Medicine Provider
Cardiology
Bonnie Ky, MD, MSCE
5.0
(195)
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center

About me

  • Director, Thalheimer Center for Cardio-Oncology
  • Director, Penn Center for Quantitative Echocardiography
  • Founders Professor of Cardio-Oncology
  • Professor of Epidemiology in Biostatistics and Epidemiology

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

195 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
she deserves it
May 2025
5.0
5.0
very knowledgeable, dedicated
April 2025
5.0
5.0
she is always professional.
April 2025
5.0
5.0
love my provider. very through i actually look forward to my visits with her

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Ky is a Penn Medicine physician.

Qualifications and experience

My research

Fanaroff AC, Orr JA, Anucha C, Kim E, Rareshide C, Echevarria M, Rodarte S, Kassabian M, Balasian E, Ky B, Volpp KGM, Armenian S. A randomized controlled trial of gamification to increase physical activity among black and Hispanic breast and prostate cancer survivors: Rationale and design of the ALLSTAR clinical trial. , Am Heart J, 280: 2025,42-51


Nikolova AP, Ky B Immune Checkpoint Inhibitors Myocarditis: The Nuts and Bolts , JACC Heart Fail, 12(10): 2024,1794-6


Nain P, Stabellini N, Makram OM, Rast J, Yerraguntla S, Gopu G, Bhave A, Seth L, Patel V, Jiang S, Malik S, Shetewi A, Montero AJ, Cullen J, Agarwal N, Wang X, Ky B, Baldassarre LA, Weintraub NL, Harris RA, Guha A. Adverse social determinants of health elevate uncontrolled hypertension risk: a cardio-oncology prospective cohort study , JNCI Cancer Spectr, 8: 2024,pkae064


Avis NE, Levine BJ, Klepin HD, Mihalko SL, Brubaker PH, Moore T, Ladd AC, Dent SF, Hackney MH, Ky B, Ntim WO, Wagner LI, Weaver KE, Hundley WG; UPBEAT study team. The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415 , Support Care Cancer, 32: 2024,528


Kim K, Kim MM, Skoufos G, Diffenderfer ES, Motlagh SAO, Kokkorakis M, Koliaki I, Morcos G, Shoniyozov K, Griffin J, Hatzigeorgiou AG, Metz JM, Lin A, Feigenberg SJ, Cengel KA, Ky B, Koumenis C, Verginadis II. FLASH Proton Radiation Therapy Mitigates Inflammatory and Fibrotic Pathways and Preserves Cardiac Function in a Preclinical Mouse Model of Radiation-Induced Heart Disease , Int J Radiat Oncol Biol Phys, 119(4): 2024,1234-1247


Mabudian L, Reding K, D'Agostino RB Jr, Heiston EM, Bellissimo MP, Olson K, Ntim WO, Klepin HD, Dressler EV, Moore T, Jordan JH, O'Connell NS, Ladd A, Weaver KE, Ky B, Wagner LI, Hackney MH, Lesser GJ, Hundley WG; UPBEAT Study Team. The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancer , Cardiooncology, 10: 2024,34


Reding KW, Szewczyk W, D'Agostino RB Jr, O'Connell NS, Vasbinder A, Bellissimo MP, Lucas AR, Sheppard VB, Sutton AL, Ky B, Lesser GJ, Hundley WG. Black-White Disparities in Submaximal Exercise Capacity Reductions in Breast Cancer Survivors: A Prospective Cohort Study , JACC CardioOncol, 6: 2024,467-469


Demissei BG, Ko K, Huang A, Lee DJ, Doucette AG, Smith AM, Wilcox NS, Reibel J, Sun L, Agarwal M, Haas NB, Hollis G, Shpilsky JE, Takvorian SU, Vaughn DJ, Chen J, Hubbard RA, Powell-Wiley T, Yancy C, Narayan V, Ky B. Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer , JACC CardioOncol, 6: 2024,390-401


Leger KJ, Absalon MJ, Demissei BG, Smith AM, Gerbing RB, Alonzo TA, Narayan HK, Hirsch BA, Pollard JA, Razzouk BI, Getz KD, Aplenc R, Kolb EA, Ky B, Cooper TM. Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report , Front Cardiovasc Med, 11: 2024,1347547


Patel RB, Silvestry FE, Komtebedde J, Solomon SD, Hasenfuß G, Litwin SE, Borlaug BA, Price MJ, Kawash R, Hummel SL, Cutlip DE, Leon MB, van Veldhuisen DJ, Rieth AJ, McKenzie S, Bugger H, Mazurek JA, Kapadia SR, Vanderheyden M, Ky B, Shah SJ. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial , JAMA Cardiol, 9: 2024,507-522


View all publications